Contract clauses steering patent disputes to a particular federal court will get more attention after the Federal Circuit ruled such a clause prevents a Massachusetts drug maker from maintaining administrative patent challenges.
The U.S. Court of Appeals for the Federal Circuit Feb. 8 ruled Nippon Shinyaku Co. Ltd. was entitled to a preliminary injunction that will force Sarepta Therapeutics Inc. to withdraw petitions seeking patent reviews at the Patent Trial and Appeal Board.
The appeals court said a 2020 agreement between the two companies required Sarepta to dispute the validity of Nippon Shinyaku’s patents in Delaware federal court.
The precedential ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.